Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases.
about
Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population.A qualitative assessment of the content validity of the ICECAP-A and EQ-5D-5L and their appropriateness for use in health research.Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.Validity of EQ-5D-5L in stroke.Design of Economic Evaluations of Mindfulness-Based Interventions: Ten Methodological Questions of Which to Be Mindful.Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?The societal burden of chronic liver diseases: results from the COME study.Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults.Cost-effectiveness of eye care services in Zambia.Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis.Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B.A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases.Evaluation of health status in patients with hepatitis c treated with and without interferon.Cross-cultural measurement equivalence of the EQ-5D-5L items for English-speaking Asians in Singapore.Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D Multi-Attribute Utility Instruments in Patients Who Have Previously Undergone Bariatric Surgery.Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases.Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement.The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.Measuring changes in health over time using the EQ-5D 3L and 5L: a head-to-head comparison of measurement properties and sensitivity to change in a German inpatient rehabilitation sample.Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values.Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries.A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D.Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting.Factors influencing on health-related quality of life in South Korean with chronic liver diseasePatients', physicians', nurses', and pharmacists' preferences on the characteristics of biologic agents used in the treatment of rheumatic diseasesReply
P2860
Q33646326-0CCF5733-F61E-4A95-819C-397536E30999Q35075900-7F94118B-4BCB-4BD0-835A-B6156BFB1A0AQ35083972-F9440BF6-810C-4375-BC32-E2F70BA43164Q35197189-AB1CC6DA-2153-4030-8B98-0B90D05DB73BQ35607322-B69AE708-9C5D-476D-867D-8BBBEDDE5F84Q35687316-78E6B334-2442-48BA-8BEB-DFF4E81A64DEQ36101037-4247AB0C-869C-478F-929C-B0B06A591D67Q36127240-9AD17E3B-F888-49E0-87CD-97E39C9CFE0BQ36140415-3B4CE082-7386-46E1-9B77-D351FAEB1AD4Q36980775-7B971345-53D3-4434-971E-CFE5120A36DEQ37621881-95D48515-758C-4058-BC46-DC2B971E3C67Q41147165-78C5F4AB-83DA-4D87-807C-DC3931071879Q42224119-772B8F14-D760-4419-85DF-274D4BCB1A73Q47418992-771955AF-2ECD-45BD-AC39-A91A2C8C0120Q47552347-046A0DC0-CF3D-440E-8D50-D55B6F775DF3Q47588361-CDA311C7-8A29-44FA-8568-011B1EAC45ACQ47732379-290D0BB5-10B8-405C-9D90-19A6B17DEBB2Q47836160-9EC80E28-90CE-4437-8620-555816F8D871Q47862404-D7081F93-371F-4B30-AF88-3ED230B8E7E1Q48036502-8DF327C7-8591-42B7-A240-B555EEE87755Q48054469-0310DF50-8D54-412F-BF4A-BFF1E75C4F33Q48055158-DA302931-B550-4E6C-8A62-AB7F0FDA1897Q48061252-12576A34-3C58-4C2A-B4C8-BF1B540A5B96Q48123615-6529607A-48C9-4F8B-ABB9-4461F538AEE3Q52603310-72A1A500-3FDC-4D20-875C-D85EC4CE2166Q52689975-96591E3A-8672-48CB-BFF1-3BC82B2AE1CCQ55235039-F4E258D4-AD33-4429-9772-940A2B79E835Q55388766-233CD970-ABD3-4459-8CC4-696F0F14551BQ57211195-997C22C2-B6F2-494D-A45A-64426C90832FQ58558578-2CD62033-2873-47B6-9635-BACFAF7F64DCQ59149891-FBF94B96-3D20-457A-9CEF-27F309418C8F
P2860
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Comparing the performance of t ...... with chronic hepatic diseases.
@en
Comparing the performance of t ...... with chronic hepatic diseases.
@nl
type
label
Comparing the performance of t ...... with chronic hepatic diseases.
@en
Comparing the performance of t ...... with chronic hepatic diseases.
@nl
prefLabel
Comparing the performance of t ...... with chronic hepatic diseases.
@en
Comparing the performance of t ...... with chronic hepatic diseases.
@nl
P2093
P2860
P1476
Comparing the performance of t ...... with chronic hepatic diseases.
@en
P2093
Anna Del Prete
Francesco Fusco
Giancarlo Cesana
Ivan Gardini
Laura Gaeta
Lorenzo G Mantovani
Luciana Scalone
Roberta Ciampichini
Stefano Fagiuoli
P2860
P2888
P304
P356
10.1007/S11136-012-0318-0
P577
2012-11-29T00:00:00Z